Symbols / INGN
INGN Chart
About
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 158.55M |
| Enterprise Value | 53.55M | Income | -25.38M | Sales | 347.03M |
| Book/sh | 7.26 | Cash/sh | 4.54 | Dividend Yield | — |
| Payout | 0.00% | Employees | 766 | IPO | — |
| P/E | — | Forward P/E | 116.80 | PEG | — |
| P/S | 0.46 | P/B | 0.80 | P/C | — |
| EV/EBITDA | -5.50 | EV/Sales | 0.15 | Quick Ratio | 2.52 |
| Current Ratio | 3.14 | Debt/Eq | 9.24 | LT Debt/Eq | — |
| EPS (ttm) | -1.00 | EPS next Y | 0.05 | EPS Growth | — |
| Revenue Growth | 4.00% | Earnings | 2026-05-06 | ROA | -6.21% |
| ROE | -13.27% | ROIC | — | Gross Margin | 44.76% |
| Oper. Margin | -6.98% | Profit Margin | -7.31% | Shs Outstand | 27.15M |
| Shs Float | 24.06M | Short Float | 3.05% | Short Ratio | 3.86 |
| Short Interest | — | 52W High | 11.94 | 52W Low | 5.48 |
| Beta | 1.79 | Avg Volume | 194.59K | Volume | 197.05K |
| Target Price | $13.00 | Recom | None | Prev Close | $5.68 |
| Price | $5.84 | Change | 2.82% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$13.00
Mean price target
2. Current target
$5.84
Latest analyst target
3. DCF / Fair value
$-11.92
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$5.84
Low
$12.00
High
$14.00
Mean
$13.00
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-06-16 | init | B. Riley Securities | — → Buy | $14 |
| 2025-05-22 | up | Needham | Hold → Buy | $12 |
| 2025-05-08 | main | Stifel | Hold → Hold | $7 |
| 2025-04-09 | reit | Needham | Hold → Hold | — |
| 2025-02-27 | reit | Needham | Hold → Hold | — |
| 2025-02-26 | reit | Needham | Hold → Hold | — |
| 2025-01-30 | reit | Needham | Hold → Hold | — |
| 2025-01-14 | reit | Needham | Hold → Hold | — |
| 2024-11-08 | reit | Needham | — → Hold | — |
| 2024-08-07 | reit | Needham | — → Hold | — |
| 2024-05-08 | main | Stifel | Hold → Hold | $7 |
| 2024-05-08 | reit | Needham | — → Hold | — |
| 2024-04-09 | reit | Needham | — → Hold | — |
| 2024-02-15 | up | William Blair | Market Perform → Outperform | — |
| 2023-11-08 | main | JP Morgan | Underweight → Underweight | $7 |
| 2023-08-08 | main | Stifel | Hold → Hold | $8 |
| 2023-08-08 | down | JP Morgan | Neutral → Underweight | $8 |
| 2023-07-14 | down | Needham | Buy → Hold | — |
| 2023-04-20 | reit | Needham | — → Buy | $26 |
| 2023-02-28 | reit | Needham | — → Buy | $26 |
- Medical tech firm Inogen commits $30M to repurchase its stock - Stock Titan ue, 24 Feb 2026 21
- Inogen Inc (NASDAQ:INGN) Stock Falls on Revenue Miss and Cautious 2026 Outlook - ChartMill ue, 24 Feb 2026 23
- Inogen (INGN) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance Wed, 25 Feb 2026 00
- Inogen (INGN) Initiates $30 Million Share Buyback Program - GuruFocus ue, 24 Feb 2026 22
- No-debt device maker Inogen eyes up to $373M in 2026 revenue - Stock Titan ue, 24 Feb 2026 21
- Inogen Posts 2025 Results and Launches Share Buyback - TipRanks ue, 24 Feb 2026 21
- Inogen Q4 2025 Earnings Call Transcript - MarketBeat Wed, 25 Feb 2026 04
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga Wed, 25 Feb 2026 12
- Inogen authorizes $30M share repurchase program; shares up - MSN Wed, 25 Feb 2026 04
- INGN Stock Gains Post Latest Launch to Expand Respiratory Care Suite - Zacks Investment Research hu, 08 Jan 2026 08
- Inogen (INGN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Nasdaq ue, 17 Feb 2026 15
- Understanding Momentum Shifts in (INGN) - Stock Traders Daily ue, 17 Feb 2026 22
- Inogen (INGN) Loses 10.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Finviz ue, 10 Feb 2026 19
- Inogen (INGN) Soars 6.6%: Is Further Upside Left in the Stock? - Yahoo Finance Wed, 11 Feb 2026 08
- Inogen (INGN) Projects Flat Revenue for Q1 2026 - GuruFocus Wed, 25 Feb 2026 00
Insider Transactions
| Date | Shares | Url | Text | Insider | Position | Transaction | Start Date | Ownership | Value |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 31566 | — | — | RAMADE GREGOIRE | Officer | — | 2025-12-01 00:00:00 | D | nan |
| 1 | 28334 | — | — | SMITH KEVIN RAYMOND MERRILL | Chief Executive Officer | — | 2025-12-01 00:00:00 | D | nan |
| 2 | 1500 | — | Stock Award(Grant) at price 7.99 per share. | SMITH KEVIN P. | General Counsel | — | 2025-08-29 00:00:00 | D | 11985.0 |
| 3 | 18135 | — | — | SMITH KEVIN P. | General Counsel | — | 2025-08-29 00:00:00 | D | nan |
| 4 | 1500 | — | Stock Award(Grant) at price 7.99 per share. | BOURQUE MICHAEL J | Chief Financial Officer | — | 2025-08-29 00:00:00 | D | 11985.0 |
| 5 | 1500 | — | Stock Award(Grant) at price 7.99 per share. | SMITH KEVIN RAYMOND MERRILL | Chief Executive Officer | — | 2025-08-29 00:00:00 | D | 11985.0 |
| 6 | 30612 | — | Stock Award(Grant) at price 0.00 per share. | SAHNEY MIRA KIRTI | Director | — | 2025-05-14 00:00:00 | D | — |
| 7 | 30612 | — | Stock Award(Grant) at price 0.00 per share. | BOEHNLEIN GLENN S | Director | — | 2025-05-14 00:00:00 | D | — |
| 8 | 30612 | — | Stock Award(Grant) at price 0.00 per share. | LADONE MARY KAY | Director | — | 2025-05-14 00:00:00 | D | — |
| 9 | 30612 | — | Stock Award(Grant) at price 0.00 per share. | MORA ELIZABETH A | Director | — | 2025-05-14 00:00:00 | D | — |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | -6.91M | -10.95M | 0.00 |
| TaxRateForCalcs | 0.02 | 0.21 | 0.21 | 0.27 |
| NormalizedEBITDA | -21.51M | -25.45M | 42.59M | 30.87M |
| TotalUnusualItems | 0.00 | -32.89M | -52.16M | 0.00 |
| TotalUnusualItemsExcludingGoodwill | 0.00 | -32.89M | -52.16M | 0.00 |
| NetIncomeFromContinuingOperationNetMinorityInterest | -35.89M | -102.45M | -83.77M | -6.33M |
| ReconciledDepreciation | 21.00M | 18.15M | 23.51M | 21.63M |
| ReconciledCostOfRevenue | 180.96M | 188.96M | 223.71M | 181.52M |
| EBITDA | -21.51M | -58.34M | -9.57M | 30.87M |
| EBIT | -42.52M | -76.49M | -33.08M | 9.24M |
| NetInterestIncome | 5.19M | 6.57M | 2.84M | 129.00K |
| InterestIncome | 5.19M | 6.57M | 2.84M | 129.00K |
| NormalizedIncome | -35.89M | -76.46M | -42.56M | -6.33M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -35.89M | -102.45M | -83.77M | -6.33M |
| TotalExpenses | 378.22M | 392.15M | 410.32M | 348.76M |
| RentExpenseSupplemental | 19.72M | 17.43M | 14.80M | 19.70M |
| TotalOperatingIncomeAsReported | -42.52M | -109.39M | -85.24M | 9.24M |
| DilutedAverageShares | 23.65M | 23.18M | 22.85M | 22.49M |
| BasicAverageShares | 23.65M | 23.18M | 22.85M | 22.49M |
| DilutedEPS | -1.52 | -4.42 | -3.67 | -0.28 |
| BasicEPS | -1.52 | -4.42 | -3.67 | -0.28 |
| DilutedNIAvailtoComStockholders | -35.89M | -102.45M | -83.77M | -6.33M |
| NetIncomeCommonStockholders | -35.89M | -102.45M | -83.77M | -6.33M |
| NetIncome | -35.89M | -102.45M | -83.77M | -6.33M |
| NetIncomeIncludingNoncontrollingInterests | -35.89M | -102.45M | -83.77M | -6.33M |
| NetIncomeContinuousOperations | -35.89M | -102.45M | -83.77M | -6.33M |
| TaxProvision | -588.00K | 105.00K | 504.00K | 14.99M |
| PretaxIncome | -36.48M | -102.34M | -83.27M | 8.66M |
| OtherIncomeExpense | 850.00K | -32.43M | -53.02M | -710.00K |
| OtherNonOperatingIncomeExpenses | 850.00K | 468.00K | -862.00K | -710.00K |
| SpecialIncomeCharges | 0.00 | -32.89M | -52.16M | 0.00 |
| GainOnSaleOfPPE | 0.00 | 0.00 | -52.16M | 0.00 |
| WriteOff | 0.00 | 32.89M | 0.00 | 0.00 |
| ImpairmentOfCapitalAssets | 32.89M | 0.00 | 0.00 | |
| NetNonOperatingInterestIncomeExpense | 5.19M | 6.57M | 2.84M | 129.00K |
| InterestIncomeNonOperating | 5.19M | 6.57M | 2.84M | 129.00K |
| OperatingIncome | -42.52M | -76.49M | -33.08M | 9.24M |
| OperatingExpense | 197.26M | 203.19M | 186.62M | 167.24M |
| ResearchAndDevelopment | 21.61M | 20.84M | 21.94M | 16.58M |
| SellingGeneralAndAdministration | 175.65M | 182.35M | 164.67M | 150.67M |
| SellingAndMarketingExpense | 103.07M | 107.09M | 120.77M | 112.81M |
| GeneralAndAdministrativeExpense | 72.58M | 75.26M | 43.91M | 37.85M |
| OtherGandA | 72.58M | 75.26M | 43.91M | 37.85M |
| GrossProfit | 154.74M | 126.70M | 153.53M | 176.48M |
| CostOfRevenue | 180.96M | 188.96M | 223.71M | 181.52M |
| TotalRevenue | 335.70M | 315.66M | 377.24M | 358.00M |
| OperatingRevenue | 335.70M | 315.66M | 377.24M | 358.00M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 23.90M | 22.94M | 22.94M | 22.73M |
| ShareIssued | 23.90M | 22.94M | 22.94M | 22.73M |
| TotalDebt | 19.41M | 21.92M | 23.28M | 26.67M |
| TangibleBookValue | 133.90M | 160.16M | 264.38M | 277.10M |
| InvestedCapital | 173.86M | 204.81M | 297.41M | 370.23M |
| WorkingCapital | 108.77M | 134.57M | 239.30M | 267.67M |
| NetTangibleAssets | 133.90M | 160.16M | 264.38M | 277.10M |
| CapitalLeaseObligations | 19.41M | 21.92M | 23.28M | 26.67M |
| CommonStockEquity | 173.86M | 204.81M | 297.41M | 370.23M |
| TotalCapitalization | 173.86M | 204.81M | 297.41M | 370.23M |
| TotalEquityGrossMinorityInterest | 173.86M | 204.81M | 297.41M | 370.23M |
| StockholdersEquity | 173.86M | 204.81M | 297.41M | 370.23M |
| GainsLossesNotAffectingRetainedEarnings | -1.50M | 1.23M | -243.00K | 1.47M |
| OtherEquityAdjustments | -1.50M | 1.23M | -243.00K | 1.47M |
| RetainedEarnings | -152.84M | -116.95M | -14.50M | 69.27M |
| AdditionalPaidInCapital | 328.17M | 320.51M | 312.13M | 299.46M |
| CapitalStock | 24.00K | 23.00K | 23.00K | 23.00K |
| CommonStock | 24.00K | 23.00K | 23.00K | 23.00K |
| TotalLiabilitiesNetMinorityInterest | 122.33M | 121.38M | 107.64M | 119.29M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 45.64M | 48.89M | 42.29M | 57.77M |
| OtherNonCurrentLiabilities | 15.39M | |||
| NonCurrentDeferredLiabilities | 12.70M | 16.77M | 10.40M | 11.86M |
| NonCurrentDeferredRevenue | 5.75M | 8.23M | 10.40M | 11.86M |
| NonCurrentDeferredTaxesLiabilities | 6.95M | 8.54M | 0.00 | 0.00 |
| LongTermDebtAndCapitalLeaseObligation | 16.59M | 18.27M | 19.76M | 23.28M |
| LongTermCapitalLeaseObligation | 16.59M | 18.27M | 19.76M | 23.28M |
| LongTermProvisions | 16.35M | 13.85M | 12.12M | 7.25M |
| CurrentLiabilities | 76.69M | 72.50M | 65.35M | 61.51M |
| OtherCurrentLiabilities | 13.00M | 10.00M | ||
| CurrentDeferredLiabilities | 6.65M | 7.98M | 8.88M | 8.57M |
| CurrentDeferredRevenue | 6.65M | 7.98M | 8.88M | 8.57M |
| CurrentDebtAndCapitalLeaseObligation | 2.81M | 3.65M | 3.52M | 3.39M |
| CurrentCapitalLeaseObligation | 2.81M | 3.65M | 3.52M | 3.39M |
| CurrentProvisions | 9.74M | 9.63M | 7.79M | 6.48M |
| PayablesAndAccruedExpenses | 44.48M | 41.23M | 45.16M | 43.07M |
| CurrentAccruedExpenses | 27.73M | 27.75M | 26.43M | 32.25M |
| Payables | 16.76M | 13.48M | 18.73M | 10.82M |
| TotalTaxPayable | 142.00K | 27.00K | 492.00K | 561.00K |
| IncomeTaxPayable | 142.00K | 27.00K | 0.00 | 75.00K |
| AccountsPayable | 16.62M | 13.45M | 18.24M | 10.26M |
| TotalAssets | 296.19M | 326.19M | 405.04M | 489.51M |
| TotalNonCurrentAssets | 110.73M | 119.13M | 100.40M | 160.33M |
| OtherNonCurrentAssets | 8.08M | 3.83M | 2.44M | 3.36M |
| NonCurrentDeferredAssets | 0.00 | |||
| NonCurrentDeferredTaxesAssets | 0.00 | |||
| GoodwillAndOtherIntangibleAssets | 39.96M | 44.65M | 33.03M | 93.13M |
| OtherIntangibleAssets | 30.49M | 34.59M | 177.00K | 60.15M |
| Goodwill | 9.46M | 10.06M | 32.85M | 32.98M |
| NetPPE | 62.70M | 70.65M | 64.92M | 63.84M |
| AccumulatedDepreciation | -44.73M | -47.84M | -51.84M | -51.67M |
| GrossPPE | 107.43M | 118.50M | 116.77M | 115.51M |
| Leases | 6.13M | 5.96M | ||
| ConstructionInProgress | 2.93M | 1.64M | ||
| OtherProperties | 107.43M | 118.50M | 116.77M | 96.03M |
| MachineryFurnitureEquipment | 12.76M | 11.75M | ||
| LandAndImprovements | 125.00K | 125.00K | ||
| Properties | 0.00 | 0.00 | ||
| CurrentAssets | 185.45M | 207.07M | 304.64M | 329.19M |
| OtherCurrentAssets | 13.12M | 13.85M | 19.19M | 26.00M |
| RestrictedCash | 3.62M | 0.00 | ||
| PrepaidAssets | 26.00M | |||
| Inventory | 24.81M | 21.84M | 34.09M | 31.87M |
| InventoriesAdjustmentsAllowances | -2.04M | -3.07M | -1.73M | -2.15M |
| FinishedGoods | 7.63M | 6.87M | 9.32M | 12.12M |
| RawMaterials | 19.22M | 18.04M | 26.50M | 21.91M |
| Receivables | 30.10M | 42.91M | 64.35M | 25.80M |
| TaxesReceivable | 538.00K | 669.00K | 1.63M | 1.34M |
| AccountsReceivable | 29.56M | 42.24M | 62.73M | 24.45M |
| AllowanceForDoubtfulAccountsReceivable | -871.00K | -2.82M | -560.00K | -862.00K |
| GrossAccountsReceivable | 30.43M | 45.06M | 63.28M | 25.31M |
| CashCashEquivalentsAndShortTermInvestments | 113.80M | 128.47M | 187.01M | 245.51M |
| OtherShortTermInvestments | 0.00 | 2.98M | 0.00 | 9.99M |
| CashAndCashEquivalents | 113.80M | 125.49M | 187.01M | 235.52M |
| CashEquivalents | 90.74M | 112.88M | 159.04M | 186.71M |
| CashFinancial | 23.05M | 12.61M | 27.97M | 48.82M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -11.18M | -30.25M | -58.75M | -434.00K |
| CapitalExpenditure | -17.09M | -27.01M | -21.22M | -24.07M |
| IncomeTaxPaidSupplementalData | 375.00K | 499.00K | 1.54M | |
| EndCashPosition | 117.42M | 125.49M | 187.01M | 235.52M |
| BeginningCashPosition | 125.49M | 187.01M | 235.52M | 211.96M |
| EffectOfExchangeRateChanges | -281.00K | 67.00K | -481.00K | -426.00K |
| ChangesInCash | -7.80M | -61.59M | -48.03M | 23.99M |
| FinancingCashFlow | 265.00K | 960.00K | 380.00K | 15.00M |
| CashFlowFromContinuingFinancingActivities | 265.00K | 960.00K | 380.00K | 15.00M |
| NetOtherFinancingCharges | -546.00K | -518.00K | -1.35M | -647.00K |
| ProceedsFromStockOptionExercised | 811.00K | 1.48M | 1.74M | 15.65M |
| InvestingCashFlow | -13.97M | -59.31M | -10.88M | -14.64M |
| CashFlowFromContinuingInvestingActivities | -13.97M | -59.31M | -10.88M | -14.64M |
| NetOtherInvestingChanges | 275.00K | 198.00K | 331.00K | 153.00K |
| NetInvestmentPurchaseAndSale | 2.84M | -2.87M | 10.01M | 9.27M |
| SaleOfInvestment | 35.50M | 24.00M | 10.01M | 19.26M |
| PurchaseOfInvestment | -32.66M | -26.87M | 0.00 | -9.99M |
| NetBusinessPurchaseAndSale | 0.00 | -29.63M | 0.00 | 0.00 |
| PurchaseOfBusiness | 0.00 | -29.63M | 0.00 | 0.00 |
| NetIntangiblesPurchaseAndSale | -2.09M | -494.00K | 0.00 | -132.00K |
| PurchaseOfIntangibles | -2.09M | -494.00K | 0.00 | -132.00K |
| NetPPEPurchaseAndSale | -15.00M | -26.52M | -21.22M | -23.93M |
| PurchaseOfPPE | -15.00M | -26.52M | -21.22M | -23.93M |
| OperatingCashFlow | 5.91M | -3.23M | -37.53M | 23.63M |
| CashFlowFromContinuingOperatingActivities | 5.91M | -3.23M | -37.53M | 23.63M |
| ChangeInWorkingCapital | -4.39M | 14.27M | -44.72M | -20.07M |
| ChangeInOtherWorkingCapital | -1.20M | 490.00K | 5.04M | 945.00K |
| ChangeInOtherCurrentLiabilities | -4.33M | -3.46M | -3.40M | 16.67M |
| ChangeInOtherCurrentAssets | 4.41M | 2.30M | 3.48M | -15.99M |
| ChangeInPayablesAndAccruedExpense | 2.92M | -9.66M | 571.00K | 2.61M |
| ChangeInAccruedExpense | 6.22M | -508.00K | -6.11M | 10.23M |
| ChangeInPayable | -3.30M | -9.15M | 6.68M | -7.62M |
| ChangeInAccountPayable | -3.41M | -9.18M | 6.76M | -6.48M |
| ChangeInTaxPayable | 115.00K | 27.00K | -82.00K | -1.14M |
| ChangeInIncomeTaxPayable | 115.00K | 27.00K | -82.00K | -1.14M |
| ChangeInPrepaidAssets | 2.41M | 5.58M | 6.80M | -8.10M |
| ChangeInInventory | -3.54M | 7.88M | -5.60M | -10.78M |
| ChangeInReceivables | -5.07M | 11.13M | -51.62M | -5.42M |
| ChangesInAccountReceivables | -5.19M | 10.14M | -51.34M | -6.13M |
| OtherNonCashItems | 3.45M | 8.88M | -15.39M | -11.60M |
| StockBasedCompensation | 7.40M | 7.43M | 12.28M | 10.94M |
| ProvisionandWriteOffofAssets | 11.12M | 13.42M | 15.45M | 13.16M |
| AssetImpairmentCharge | 0.00 | 32.89M | 0.00 | 0.00 |
| DeferredTax | -1.15M | -251.00K | 0.00 | 14.44M |
| DeferredIncomeTax | -1.15M | -251.00K | 0.00 | 14.44M |
| DepreciationAmortizationDepletion | 21.00M | 18.15M | 23.51M | 21.63M |
| DepreciationAndAmortization | 21.00M | 18.15M | 23.51M | 21.63M |
| OperatingGainsLosses | 4.37M | 4.42M | 55.10M | 1.46M |
| GainLossOnSaleOfPPE | -165.00K | -84.00K | 52.01M | 1.46M |
| NetIncomeFromContinuingOperations | -35.89M | -102.45M | -83.77M | -6.33M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for INGN
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|